50 Billion vs. 100 Billion Exosomes: Does a Higher Count Mean Better?

When comparing exosome products, one number tends to dominate the label:

50 billion. 100 billion. 150 billion.

It's natural to assume that more must be better.

But extracellular-vesicle products aren't like buying a larger bottle of the same product. A product advertised as containing 100 billion particles is not automatically better than one containing 50 billion.

The number matters—but so does how that number was measured, what those particles were characterized as, and what documentation supports the finished product.

Here's what buyers should look for.

What Does “50 Billion Exosomes” Actually Mean?

According to KWEHEALTH, HydroKarma's 50-billion designation means 50 billion exosomes per vial, in addition to other extracellular vesicles naturally present in the product.

A particle-count claim should immediately lead to another question:

How was that number measured?

Different analytical technologies detect and count particles in different ways. Research has shown that measurements of extracellular-vesicle concentration can vary between analytical platforms because the instruments use different detection principles and have different limitations.

That means 40 billion particles reported by Company A and 100 billion reported by Company B may not be an apples-to-apples comparison if different measurement methods were used.

For a deeper explanation, see How Are Extracellular Vesicle Particle Counts Measured?.

A Particle Count Alone Doesn't Tell You What Was Counted

There's another important distinction: a particle count describes how many particles an instrument detected, not what those particles are.

An instrument may detect particles within a particular measurement range, but simply detecting a particle doesn't establish its biological identity.

That's one reason MISEV2023—the International Society for Extracellular Vesicles' consensus guidance—emphasizes complementary approaches to EV characterization rather than relying on a single measurement.

So when a supplier advertises “100 billion exosomes” with no supporting documentation, don't stop at the number.

Look at what other evidence supports the claim. Particle size, EV-associated markers, analytical methods and other characterization data can provide information that particle count alone cannot.

See Understanding Extracellular Vesicle Characterization and Testing for a closer look at those measurements.

100 Billion From Another Company vs. HydroKarma's 50 Billion

Now consider a practical comparison.

Suppose one company advertises:

100 billion exosomes

while a HydroKarma vial is documented as:

50 billion EV per 3 mL vial

Does that automatically make the 100-billion product twice as good?

No.

According to KWEHEALTH's batch-specific documentation for HydroKarma lot KH-0007DE, the finished vial reports 50 billion EV per 3 mL, with particle quantity and size measured using Spectradyne F-MRPS.

The same batch documentation reports additional characterization and finished-product testing, including:

• D10, D50 and D90 particle-size measurements
• CD9, CD63 and CD81 results
• total protein
• particle-to-protein ratio
• cell count
• zeta potential
• endotoxin
• sterility
• osmolality
• particulate matter

Just as important is how much batch-specific information accompanies that number.

A competing product advertising 100 billion particles may have equally comprehensive or even more extensive documentation. If it does, compare the evidence behind both products.

Compare the Evidence, Not Just the Number

Imagine these two hypothetical products:

Based on the information available, Product B is clearly the better-documented choice.

Product A advertises twice the particle count, but the larger number tells you very little without supporting information. You don't know how those particles were counted, what size distribution was measured, whether EV-associated markers were examined, or what the finished-product testing showed.

Product B advertises fewer particles, but it gives the buyer substantially more information about what was measured and how the finished product was characterized and tested.

The meaningful difference is the documentation behind the number — what was counted, how it was measured, and what supporting characterization is available.

If Product A later provides equally strong or stronger batch-specific documentation, then you can make a meaningful comparison between the two products.

Bigger Numbers Can Be Valuable—When They're Properly Documented

There's nothing inherently wrong with a 100-billion-particle product.

If a manufacturer documents 100 billion particles using an identified analytical method and backs that number with meaningful characterization and batch-specific testing, that's useful information.

The mistake is assuming:

100 billion > 50 billion = better product

without looking at anything else.

Instead, ask:

• How were the 100 billion particles measured?
• What else was characterized?
• Is there a batch-specific COA?
• What finished-product testing was performed?
• Can those results be traced to the lot being purchased?

When comparing HydroKarma's reported 50 billion EV per 3 mL vial with another company's 100-billion-particle product, compare the documentation behind both numbers.

Look at the measurement method.

Check the characterization.

Review the batch-specific testing.

Verify that the documentation corresponds to the product and lot being sold.

Our guide How to Read an Exosome Certificate of Analysis explains what to look for in that documentation.

And if all you can find for a competing product is “100 billion exosomes” prominently displayed on a website, that number alone doesn't provide enough information to determine whether the product is a better choice simply because the number is bigger.

For a broader buying checklist, see Planning on Buying Exosomes? Here’s What to Look for Before You Buy.

The Bottom Line

A larger particle count alone is not evidence of a better product. HydroKarma's documentation reports 50 billion EV per 3 mL vial, and according to KWEHEALTH that designation means 50 billion exosomes per vial, in addition to other extracellular vesicles naturally present in the product.

Particle quantity is one part of the picture.

The measurement method, particle characterization, EV-associated markers, batch-specific testing, traceability and manufacturing transparency tell you much more about what stands behind that number.

So don't simply ask:

“Which vial has more?”

Ask:

“Which product gives me the evidence to back up what it's claiming?”